Acquisition

Medtronic acquires Intersect ENT

Medtronic acquired Intersect ENT for ~$1.1 billion (announced Aug 2021; completed May 13, 2022; FTC required divesting Fiagon), a maker of PROPEL and SINUVA sinus implants. (month-precision announce)

full acquisition · Completed · $1.1B (reported, approximate) · verified

Track Medtronic acquires Intersect ENT

Machine-readable surfaces

Markdown mirror: /acquisitions/medtronic-acquires-intersect-ent-2022.md
JSON-LD: embedded in this page’s head
REST API: /v1/acquisitions/medtronic-acquires-intersect-ent-2022
Revision history: /acquisitions/medtronic-acquires-intersect-ent-2022/history
Data documentation: /data
Query this programmatically: Deploy MCP

b0d1e6f8-60fd-44b5-b54b-39433b9c0cfb

Parties

Acquirer: Medtronic
Acquired: Intersect ENT

Timeline

Announced: 2021-08-01
Closed: 2022-05-13

Sources (1)

https://news.medtronic.com/2022-05-13-Medtronic-completes-acquisition-of-Intersect-ENT

Deploy Watch

Track this acquisition.

We notify you when the structure updates, the valuation moves between bases, or a related corporate-state event surfaces.